Home › Dermatomyositis
Pag-aaral pangklinika para sa Dermatomyositis na nagre-recruit sa U.S.
26 pag-aaral para sa Dermatomyositis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Durham, NC8 pag-aaral
- Washington, DC7 pag-aaral
- New York City, NY5 pag-aaral
- Pittsburgh, PA5 pag-aaral
- Houston, TX5 pag-aaral
- Boston, MA5 pag-aaral
- Baltimore, MD4 pag-aaral
- Philadelphia, PA4 pag-aaral
- Miami, FL4 pag-aaral
- Kansas City, KS3 pag-aaral
- Aurora, CO3 pag-aaral
- Phoenix, AZ3 pag-aaral
- Jacksonville, FL3 pag-aaral
- Cleveland, OH3 pag-aaral
- New Haven, CT3 pag-aaral
Ayos sa estado
- Arizona4 pag-aaral
- California9 pag-aaral
- Colorado4 pag-aaral
- Connecticut3 pag-aaral
- Florida7 pag-aaral
- Illinois3 pag-aaral
- Kansas4 pag-aaral
- Maryland9 pag-aaral
- Massachusetts5 pag-aaral
- New York6 pag-aaral
- North Carolina8 pag-aaral
- Ohio5 pag-aaral
- Pennsylvania7 pag-aaral
- Texas6 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
Nagre-recruitPhase 2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07111065Environmental Risk Factors for the Anti-synthetase Syndrome
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT01276470Natural History of Inflammatory Muscle Diseases
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 120 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT05738824A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06455449Adult and Juvenile Myositis
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT00017914Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Nagre-recruitPhase 2/3
Edad 6 hanggang 75 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06154252A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06916806A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05895786A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Nagre-recruitPhase 1
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07085104FT839 in Autoimmune Diseases
Nagre-recruitPhase 1/2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07800871A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06698796Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07486869Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT07089121Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Nagre-recruitPhase 1
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06371417A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07115745Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT07138898Intralesional Injection of STS in Treatment of Calcinosis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT06672822Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT07160205Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2026 · NCT02945345Rheumatology Patient Registry and Biorepository
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT04402086A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 11, 2026 · NCT07403188MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Nagre-recruitObservasyonal na pag-aaral
Edad 7 pataas · Lahat ng kasarian · Na-update Ene 28, 2026 · NCT07374107Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
Nagre-recruitPhase 2
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Okt 8, 2025 · NCT06857240Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
Nagre-recruitPhase 1
Edad 25 hanggang 72 · Lahat ng kasarian · Na-update May 21, 2025 · NCT06298019Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.